Premium
Implantable Cardioverter Defibrillator:
Author(s) -
FAIN ERIC S.,
WINKLE ROGER A.
Publication year - 1993
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/j.1540-8167.1993.tb01225.x
Subject(s) - medicine , cardioversion , defibrillation , cardiology , implantable cardioverter defibrillator , defibrillation threshold , bradycardia , atrial fibrillation , heart rate , blood pressure
Implantable Cardioverter Defibrillator. The Ventritex® Cadence® Model V‐100 Tiered Therapy Defibrillator is a third generation antitachyarrhythmia device currently completing clinical trials in the United States. The implantable pulse generator is capable of high energy detibrillation, low energy cardioversion, as well as antitachycardia and bradycardia pacing. In addition, this microprocessor controlled device can deliver monophasic or biphasic defibrillation/cardioversion shocks, is noncommitted to deliver shock therapy after initiating charging for defibrillation or cardioversion therapy, and can store electrograms of spontaneous tachyarrhythmia episodes. These expanded device capabilities should improve therapy efficacy and patient management, and represent a major advance in the treatment of patients with ventricular tachyarrhythmias, ( J Cardiovasc Electrophysiol, Vol. 4, pp. 211–223, April 1993 )